Vyome Holdings HIND
NASDAQ HIND
$1.91 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Vyome Holdings (HIND) Other Accumulated Expenses (2015 - 2026)

Updated

Vyome Holdings (HIND) recorded Other Accumulated Expenses of $107,660 in Q2 2026, up 99.4% from $54,000 a year earlier but down 52.7% from the prior quarter.

Analysis

Vyome Holdings (HIND) Other Accumulated Expenses (2015 - 2026) Analysis & Trends

At the end of FY2025, Vyome Holdings reported Other Accumulated Expenses of $341,835, up 216.7% from FY2024.

  • Annual Other Accumulated Expenses has a five-year compound annual growth rate of -7.8% (FY2020 to FY2025).
  • Across earlier years, Other Accumulated Expenses came in at $107,937 in FY2024 (+86.1%), $58,000 in FY2023 (-88.2%), $491,000 in FY2022 (+63.1%) and $301,000 in FY2021 (-41.4%).
  • Quarterly Other Accumulated Expenses has ranged from $45,000 in Q3 2024 to $491,000 in Q4 2022 over the past five years.
  • On a year-over-year basis, Other Accumulated Expenses has increased for five consecutive quarters, with growth averaging 104.4% over the last eight quarters.
  • Peak year-over-year performance for Other Accumulated Expenses in the last five years was growth of 384.6% in Q1 2026, against a decline of 93.3% in Q1 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $227,766 (Q1 2026), $341,835 (Q4 2025) and $93,204 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Vyome Holdings 13.41 Mn -12.70 Mn 11,658.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 107,660.00
Mar 31, 2026 227,766.00
Dec 31, 2025 341,835.00
Sep 30, 2025 93,204.00
Jun 30, 2025 54,000.00
Mar 31, 2025 47,000.00
Dec 31, 2024 107,937.00
Sep 30, 2024 45,000.00
Jun 30, 2024 47,000.00
Mar 31, 2024 56,000.00
Dec 31, 2023 58,000.00
Sep 30, 2023 105,000.00
Jun 30, 2023 94,000.00
Mar 31, 2023 345,000.00
Dec 31, 2022 491,000.00
Sep 30, 2022 266,000.00
Jun 30, 2022 222,000.00
Mar 31, 2022 314,000.00
Dec 31, 2021 301,000.00
Sep 30, 2021 389,000.00
API Access

Vyome Holdings Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=HIND&period=max&api_key=YOUR_API_KEY